Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor

Respiratory Medicine

Volumn 98, Issue 2, 2004, Pages 123-125

  Zamarrón, Carlos ^a   Maceiras, Francisco ^b   González, Javier ^a   Gömez Reino, Juan J ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

Author keywords

Infliximab; Obstructive sleep apnea; Rheumatoid arthritis; TNF

Indexed keywords

INFLIXIMAB; MONOCLONAL ANTIBODY; OXYGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AROUSAL; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; FATIGUE; FEMALE; HUMAN; OXYGEN SATURATION; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SLEEP APNEA SYNDROME; SNORING; SOMNOLENCE;

EID: 0842345465     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2003.09.004     Document Type: Article

References (16)

1. Feldman M, Elliot MJ, Woody JN, Maini RN. Anti-tumor necrosis factor alpha therapy of RA. Adv Immunol 1997; 64:283-350.
2. Lipsky PE, Van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
3. Krueger JM, Obal Jr F, Fang J. Humorat regulation of physiological sleep: cytokines and GHRH. J Sleep Res 1999;8(Suppl 1):53-9.
4. Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokine. Am J Respir Crit Care Med 1996;153:1080-6.
5. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-6.
6. Vgontzas A, Papanivolau D, Bixter E, Hopper K, Lotsikas A, Kales A, Chrousos G. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistence and hypercytokinemia. J Clin Endocrinol Metab 2000;85: 1151-8.
7. Arnett FC, Edgeworth SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis. Arthritis Rheum 1988;31:315-24.
8. Drossaers-Bakker KW, Hamburger HL, Bongartz EB, Dijkmans BA, Van Soesbergen RM. Sleep apnea caused by rheumatoid arthritis. Br J Rheumatol 1998;37:889-94.
9. Finck BN, Johnson RW. Tumor necrosis factor TNFα induces leptin production through the p55 TNF receptor. Am J Physiol Regulatory Integrative Comp Physiol 2000;278: R537-43.
10. Saarelainen S, Lahtela J, Kallonen E. Effect of nasal CPAP treatment on insuling sensitivity and plasma leptin. J Sleep Res 1997;6:146-7.
11. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. Leptin, obesity, and respiratory function. Respir Physiol 2000;119:163-70.
12. Polotsky W, Wilson JA, Smaldone MC, Haines AS, Hurn PD, Tankersley CG, Smith PL, Schwartz AR, O'Donnell CP. Female gender exacerbates respiratory depression in leptin-deficient obesity. Am J Respir Crit Care Med 2001;15:1470-5.
13. Feldman M, Brennan FM, Maini RN. Role of cytokines in RA. Annu Rev Immunol 1996;14:397-440.
14. Drewes AM, Svendsen L, Taagholt SJ, Bjerregard K, Nielsen KD, Hansen B. Sleep in RA: a comparison with healthy subjects and studies of sleep/wake interactions. Br J Rheumatol 1998;37:71-81.
15. Kubota T, Fang J, Guan Z, Brown RA, Krueger JM. Vagotomy attenuates tumour necrosis factor-α-induced sleep and EEG δ-activity in rats. Am J Physiol Regulatory Integrative Comp Physiol 2001;280:R1213-20.
16. Malow BA, Edwards J, Marzec M, Sagher O, Fromes G. Effects of vagus nerve stimulation on respiration during sleep: a pilot study. Neurology 2000;55:1450-4.